Top Markets
Coin of the day
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Hisse Senetlerindeki Sıralama #31814
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Hisse Fiyatı
$0.90225185
Son senkronizasyon: 2025-02-16
Piyasa Değeri
$11.99M
Değişim (1 gün)
0.48%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Endymed Ltd (ENDY)

Kategori

Endymed Ltd (ENDY) için kazanç
Sep 2024 itibarıyla kazanç TTM: $-2.02M
Endymed Ltd şirketinin en son finansal raporlarına göre, mevcut kazancı $-2.02M'dir. 2022 yılında şirket $1.71M kazanç elde etti, bu 2021 yılındaki $2.65M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Endymed Ltd için kazanç geçmişi 2013 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-2.02M -291.90%
2023 $1.05M -38.42%
2022 $1.71M -35.68%
2021 $2.65M 760.71%
2020 $308.00K -82.36%
2019 $1.75M -13.61%
2018 $2.02M -174.82%
2017 $-2.70M -18.40%
2016 $-3.31M -13.58%
2015 $-3.83M -7,326.42%
2014 $53.00K -114.68%
2013 $-361.00K 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$7.51B -372,854.34%
US
$5.15B -255,583.87%
US
$5.56B -276,179.40%
IE
$3.86B -191,712.90%
US
$1.42B -70,452.36%
US